Real talk about psychopharmacology, clinical confidence, and building a practice you love — from Lindsay and the Fellowship faculty.
More Articles
A 2026 JAMA Psychiatry RCT found clozapine outperformed second-line options after one failed antipsychotic in first-episode psychosis. Here's what PMHNPs should know about early clozapine use, post-REMS monitoring, and building prescribing confidence.
Psychotic symptoms can present across a wide range of psychiatric and medical conditions, making accurate differential diagnosis essential.
The FDA just approved Bysanti (milsaperidone) for bipolar I and schizophrenia. Here's what PMHNPs need to know about dosing, monitoring, and where it fits in your prescribing toolkit.